- Home
- CCEL vs WHWK Comparison
CCEL vs WHWK Comparison
Compare CCEL & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- WHWK
- Stock Information
- Founded
- CCEL 1989
- WHWK 2007
- Country
- CCEL United States
- WHWK United States
- Employees
- CCEL N/A
- WHWK N/A
- Industry
- CCEL Managed Health Care
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- WHWK Health Care
- Exchange
- CCEL Nasdaq
- WHWK Nasdaq
- Market Cap
- CCEL 51.9M
- WHWK 48.3M
- IPO Year
- CCEL 1997
- WHWK N/A
- Fundamental
- Price
- CCEL $5.12
- WHWK $1.69
- Analyst Decision
- CCEL Strong Buy
- WHWK
- Analyst Count
- CCEL 1
- WHWK 0
- Target Price
- CCEL $8.50
- WHWK N/A
- AVG Volume (30 Days)
- CCEL 10.1K
- WHWK 143.2K
- Earning Date
- CCEL 07-14-2025
- WHWK 05-08-2025
- Dividend Yield
- CCEL 7.81%
- WHWK N/A
- EPS Growth
- CCEL N/A
- WHWK N/A
- EPS
- CCEL 0.01
- WHWK 0.91
- Revenue
- CCEL $32,102,750.00
- WHWK $27,775,000.00
- Revenue This Year
- CCEL $2.49
- WHWK $40.15
- Revenue Next Year
- CCEL $0.95
- WHWK N/A
- P/E Ratio
- CCEL $321.51
- WHWK $1.85
- Revenue Growth
- CCEL 2.33
- WHWK 16.51
- 52 Week Low
- CCEL $4.75
- WHWK $1.21
- 52 Week High
- CCEL $9.43
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- CCEL 48.65
- WHWK N/A
- Support Level
- CCEL $4.79
- WHWK N/A
- Resistance Level
- CCEL $5.15
- WHWK N/A
- Average True Range (ATR)
- CCEL 0.17
- WHWK 0.00
- MACD
- CCEL 0.05
- WHWK 0.00
- Stochastic Oscillator
- CCEL 63.79
- WHWK 0.00
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.